Colorectal cancer (CRC) is one of the most common cancers in the world. About two third of
patients with CRC will develop distant recurrence at some point in time. Liver is the most …

Background Checkpoint inhibition has radically improved the perspective for patients with
metastatic cancer, but predicting who will not respond with high certainty remains difficult …

Abstract Background Although the Barcelona Clinic Liver Cancer (BCLC) staging system
has been largely adopted in clinical practice, recent studies have emphasized the need for …

Introduction Combining lenvatinib with a programmed cell death protein-1 (PD-1) inhibitor
has been explored for the treatment of un-resectable hepatocellular carcinoma (uHCC). This …

Background This study sought to develop a clinical risk score for resectable colorectal liver
metastasis (CRLM) by combining clinicopathological and clinically available biological …

Importance Portal vein embolization (PVE) has been implemented in patients with extensive
colorectal liver metastases to increase the number of patients able to undergo liver …

Objective: The objective of the current study was to define surgical outcomes after resection
of multinodular hepatocellular carcinoma (HCC) beyond the Milan criteria, and develop a …

Background More than 50% of all patients with colorectal cancer (CRC) develop liver
metastases (CLM), a clinical condition characterized by poor prognosis and lack of reliable …

Liver transplantation (LT) for colorectal liver metastasis (CRLM) may provide excellent
survival rates in patients with unresectable disease. High tumor load is a risk factor for …

Liver transplantation (LT) listing criteria for hepatocellular carcinoma (HCC) remain
controversial. To optimize the utility of limited donor organs, this study aims to leverage …